May 23, 2019 Affimed turns its back on T-cell recruitment The German group’s decision to switch focus to innate immunity had been on the cards since a deal with Roche last August.
December 10, 2018 Macrogenics’ safety scare could be contagious It could be hard for Macrogenics to shake off new safety concerns, whether it is the DART bispecific construct or its protein target that is to blame.
